Memory loss and difficulties with thinking associated with Alzheimer's disease (AD) may be
due to a deficiency in the brain of a fatty acid named DHA. The aim of this trial is to see
if dietary supplementation with a preparation, rich in DHA, will halt cognitive impairment in
AD patients